Ottobock SE & Co. KGaA Net Assets

Latest as of June 2026: €402.20 Million EUR ≈ $470.21 Million USD

Ottobock SE & Co. KGaA net assets. Based on the latest financial reports, Ottobock SE & Co. KGaA (OBCK) has net assets worth €402.20 Million EUR (≈ $470.21 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.26 Billion ≈ $2.64 Billion USD) and total liabilities (€1.85 Billion ≈ $2.17 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Ottobock SE & Co. KGaA capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Key Net Assets Metrics

Metric Value
Current Net Assets €402.20 Million
% of Total Assets 17.82%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Net Assets of Ottobock SE & Co. KGaA (2025–2025)

Net assets of Ottobock SE & Co. KGaA from 2025 to 2025. This chart illustrates how Ottobock SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. See OBCK equity financing ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Ottobock SE & Co. KGaA (2025–2025)

The table below shows the annual net assets of Ottobock SE & Co. KGaA from 2025 to 2025. For live market cap and overall valuation, see Ottobock SE & Co. KGaA stock valuation.

Year Net Assets Change
2025-12-31 €397.50 Million
≈ $464.72 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Ottobock SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

Ottobock SE & Co. KGaA Net Assets Breakdown (December 2025)

Ottobock SE & Co. KGaA net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings €223.40 Million 57.27%
Other Components €166.70 Million 42.73%
Total Equity €390.10 Million 100.00%

Ottobock SE & Co. KGaA Competitors by Market Cap

The table below lists competitors of Ottobock SE & Co. KGaA ranked by their market capitalization.

Company Market Cap
Welspun Living Limited
NSE:WELSPUNLIV
$2.54 Billion
Four Corners Property Trust Inc
NYSE:FCPT
$2.54 Billion
Qingdao Hanhe Cable Co Ltd
SHE:002498
$2.55 Billion
Asmedia Technology Inc
TW:5269
$2.55 Billion
People.Cn Co Ltd
SHG:603000
$2.54 Billion
Sumber Alfaria Trijaya Tbk
JK:AMRT
$2.54 Billion
Maple Leaf Foods Inc.
TO:MFI
$2.54 Billion
First Merchants Corporation
NASDAQ:FRME
$2.54 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ottobock SE & Co. KGaA's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares Ottobock SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 6.44x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2025-12-31 €6.10 €39.25 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ottobock SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 23.12%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.37%
  • • Asset Turnover: 0.82x
  • • Equity Multiplier: 5.25x

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2025 23.12% 5.37% 0.82x 5.25x €51.19 Million

Industry Comparison

This section compares Ottobock SE & Co. KGaA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $1,810,607,466
  • Average return on equity (ROE) among peers: -86.21%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ottobock SE & Co. KGaA (OBCK) €402.20 Million 23.12% 4.61x $2.54 Billion
SCHOTT Pharma AG & Co. KGaA (1SXP) $315.66 Million 24.55% 0.89x $2.39 Billion
CONVATEC GRP UNSP.ADR /4 (2CVU) $1.61 Billion 3.91% 1.23x $5.07 Billion
RENAU.UNSP.ARD 1/5 EO-20 (56S0) $2.67 Billion 11.61% 1.89x $17.02 Billion
MEDIMI AB AK (79T) $332.69K -959.52% 4.12x $1.70 Million
TEVANO SYSTEMS HLDGS INC. (7RBA) $-1.31 Million 0.00% 0.00x $210.67K
STEVANATO GROUP SPA O.N. (87N) $1.13 Billion 12.86% 0.83x $1.05 Billion
Carl Zeiss Meditec AG (AFX) $2.03 Billion 14.48% 0.39x $2.23 Billion
CARL ZEISS MEDITEC ADR 1 (AFXA) $2.17 Billion 13.36% 0.40x $2.14 Billion
Bio-gate AG (BIG1) $4.25 Million -42.46% 0.46x $7.12 Million
COLOPLAST SP.ADR 1/10 DK1 (CBH) $8.17 Billion 59.07% 0.94x $12.73 Billion

About Ottobock SE & Co. KGaA

XETRA:OBCK Germany Medical Instruments & Supplies
Market Cap
$2.94 Billion
€2.51 Billion EUR
Market Cap Rank
#5207 Global
#852 in Germany
Share Price
€39.25
Change (1 day)
-2.00%
52-Week Range
€39.20 - €75.70
All Time High
€75.70
About

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of p… Read more